[4] [4] ERRICO S, BEDOCCHI D, DROMMI M, et al. Forensic pathological study of methadone-related deaths in the Genoa (Italy) district: A six-year study[J]. J Forensic Leg Med, 2021, 79: 102149. doi: 10.1016/j.jflm.2021.102149.

[11] [11] WHITE J M, IRVINE R J. Mechanisms of fatal opioid overdose[J]. Addiction, 1999, 94(7): 961−972. doi: 10.1046/j.1360-0443.1999.9479612.x.

[28] [28] HON K L, HO J K, HUNG KL, et al. Poisoning necessitating pediatric ICU admissions: Size of pupils does matter[J]. J Natl Med Assoc, 2008, 100(8): 952−956. doi: 10.1016/S0027-9684(15)31411-5.

[43] [43] GARRIDO M J, TROCNIZ I F. Methadone: A review of its pharmacokinetic/pharmacodynamic properties[J]. J Pharmacol Toxicol Methods, 1999, 42(2): 61−66. doi: 10.1016/s1056-8719(00)00043-5.

[44] [44] CORLISS R F, MANDAL R, SORIANO B J. Bilateral acute necrosis of the globi pallidi and rhabdomyolysis due to combined methadone and benzodiazepine toxicity[J]. Am J Forensic Med Pathol, 2013, 34(1): 1−4. doi: 10.1097/PAF.0b013e31823a8b1e.

[45] [45] LIN J H, YAMAZAKI M. Role of P-glycoprotein in pharmacokinetics: Clinical implications[J]. Clin Pharmacokinet, 2003, 42(1): 59−98. doi: 10.2165/00003088-200342010-00003.

[46] [46] MERCER S L, COOP A. Opioid analgesics and P-glycoprotein efflux transporters: A potential systems-level contribution to analgesic tolerance[J]. Curr Top Med Chem, 2011, 11(9): 1157−1164. doi: 10.2174/156802611795371288.

[47] [47] CRETTOL S, DGLON J J, BESSON J, et al. ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment[J]. Clin Pharmacol Ther, 2006, 80(6): 668−681. doi: 10.1016/j.clpt.2006.09.012.

[48] [48] FONSECA F, DE LA TORRE R, DAZ L, et al. Contribution of cytochrome P450 andABCB1genetic variability on methadone pharmacokinetics, dose requirements, and response[J]. PLoS One, 2011, 6(5): e19527. doi: 10.1371/journal.pone.0019527.

[49] [49] RICHARDS-WAUGH L L, PRIMERANO D A, DEMENTIEVA Y, et al. Fatal methadone toxicity: Potential role of CYP3A4 genetic polymorphism[J]. J Anal Toxicol, 2014, 38(8): 541−547. doi: 10.1093/jat/bku091.

[50] [50] AHMAD T, VALENTOVIC M A, RANKIN G O. Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics[J]. Biochem Pharmacol, 2018, 153: 196−204. doi: 10.1016/j.bcp.2018.02.020.

[51] [51] SCHULZ M, SCHMOLDT A. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics[J]. Pharmazie, 2003, 58(7): 447−474.

[55] [55] BEHZADI M, JOUKAR S, BEIK A. Opioids and cardiac arrhythmia: A literature review[J]. Med Princ Pract, 2018, 27(5): 401−414. doi: 10.1159/000492616.